Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications

Journal of Managed Care Pharmacy

Volumn 15, Issue 3, 2009, Pages 253-261

  Hill, Shaynan W ^a   Varker, Andrew S ^b   Karlage, Kelly ^c   Myrdal, Paul B ^c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b Phoenix Veterans Affairs Health Care System   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; LISINOPRIL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; SIMVASTATIN; WARFARIN;

ARTICLE; CONTROLLED STUDY; DRUG CONTENT UNIFORMITY; DRUG DETERMINATION; DRUG FORMULARY; DRUG WEIGHT UNIFORMITY; HALF TABLET; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; TABLET; TABLET FORMULATION;

EID: 65449161776     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2009.15.3.253     Document Type: Article

References (13)

1. Cohen CI, Cohen SI. Potential cost savings from pill splitting of newer psychotropic medications. Psychiatr Serv. 2000;51(4):527-29.
2. Cohen CI, Cohen SI. Potential savings from splitting newer antidepressant medications. CNS Drugs. 2002;16(5):359-60.
3. Miller DP, Furberg CD, Small RH, et al. Controlling prescription drug expenditures: a report of success. Am J Manag Care. 2007;13(8):473-80. Available at: http://www.ajmc.com/files/articlefiles/ AJMC_07auf_Miller473to480.pdf. Accessed February 5, 2009.
4. Stafford RS, Radley DC. The potential of pill splitting to achieve cost savings. Am J Manag Care. 2002;8:706-12. Available at: http://www.ajmc.com/files/articlefiles/AJMC2002augStafford706_712.pdf. Accessed February 5, 2009.
5. The Official Compendia of Standards, USP28/NF23. Rockville, MD: United States Pharmacopeia Convention, Inc. 2005 Official Monographs and Uniformity of Dosage Units.
6. Teng J, Song CK, Williams RL, Polli JE. Lack of medication dose uniformity in commonly split tablets. J Am Pharm Assoc (Wash). 2002;42(2):195-99.
7. Polli JE, Kim S, Martin BR. Weight uniformity of split tablets required by a Veterans Affairs policy. J Manag Care Pharm. 2003;9(5):401-07. Available at: http://www.amcp.org/data/jmcp/ Research-401-407.pdf.
8. Cook TJ, Edwards S, Gyemah C, Shah M, Shah I, Fox T. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. J Am Pharm Assoc (2003). 2004;44(5):583-86.
9. Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc (Wash). 2002;42(2):200-05.
10. Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. Ann Pharmacother. 2002;36(2):205-09.
11. Gee M, Hasson NK, Hahn T, Ryono R. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm. 2002;8(6):453-58. Available at: http://www.amcp.org/data/jmcp/Research-453-458.pdf.
12. Parra D, Beckey NP, Raval HS, et al., for the Veterans Integrated Service Network 8 Pharmacy Benefits Management Utilization Committee. Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol. Am J Cardiol. 2005;95(12):1481-83.
13. Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. J Clin Outcomes Manage. 2000;7(4):22-24.